Childhood cancers trials in Spain

In Spain 152 Also abroad 2459

152 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Where
Barcelona
Age
1 year and over
People
500 worldwide
Run by
Autolus Limited
See details and how to joinNCT03628612
Phase 2Enrolling by invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Where
Barcelona, Esplugues de Llobregat, L'Hospitalet de Llobregat, Salamanca
People
1,500 worldwide
Run by
Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00
Phase 2Not yet taking people in Spain
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Where
Barcelona, Madrid
People
51 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07679269 · EU 2026-525890-38-00
Phase 1/2Taking people
A Phase 1/2 study of Enzomenib (DSP-5336) in Patients with Acute leukemia
Where
Albacete, Badalona, Barcelona, Cáceres, Las Palmas de Gran Canaria, Madrid, Oviedo, Salamanca, Santander, Santiago de Compostela, Valencia
People
94 worldwide
Run by
Sumitomo Pharma America Inc.
See details and how to join2022-502741-10-00 · EU 2022-502741-10-00
No phaseNot yet taking people in Spain
Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
Where
Barcelona
Age
10 years to 40 years
People
120 worldwide
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07558395
Phase 3Taking people
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
Where
Barakaldo, Barcelona, Esplugues De Llobregat, Madrid, Sevilla, Valencia
Age
Up to 17 years
People
301 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501456-28-00 · EU 2022-501456-28-00
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Oviedo, Salamanca
Age
12 years to 100 years
People
240 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00
Phase 1Taking people
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Where
Barcelona, Madrid
Age
12 years to 85 years
People
411 worldwide
Run by
Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00
Phase 3Taking people
SIOP RANDOMET 2017
Where
Barakaldo, Barcelona, Madrid, Málaga, Sevilla, Valencia
Age
Up to 17 years
People
409 worldwide
Run by
GPOH gGmbH
See details and how to join2023-508926-91-00 · EU 2023-508926-91-00
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Barcelona, Murcia, Oviedo
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
Phase 2Taking people
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Where
Barcelona, Esplugues de Llobregat, Madrid
Age
Up to 17 years
People
16 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-522138-29-00 · EU 2025-522138-29-00
No phaseTaking people
Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation
Where
Madrid
Age
4 years to 21 years
People
48
Run by
Alejandro Lucia
See details and how to joinNCT06300515
Phase 1Taking people
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
Where
Sevilla
People
7 worldwide
Run by
USWM Ct LLC
See details and how to join2024-513033-21-00 · EU 2024-513033-21-00
Phase 2Taking people
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Where
Barcelona, Madrid, Pamplona, Valencia
Age
12 years and over
People
100 worldwide
Run by
AbbVie
See details and how to joinNCT07196644 · EU 2024-518871-74-00
No phaseTaking people
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Where
Alicante, Barakaldo, Barcelona, Fuencarral-El Pardo, Madrid, Murcia, Palma de Mallorca, Santander, Santiago de Compostela, Seville, Valencia, Zaragoza
Age
0 years to 45 years
People
500 worldwide
Run by
Mats Heyman
See details and how to joinNCT03911128
No phaseTaking people
Cerebellar Mutism Syndrome Study
Where
Barcelona
Age
Up to 18 years
People
2,000 worldwide
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766
Phase 3Taking people
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Where
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Palma, Sevilla, Valencia, Zaragoza
Age
0 years to 45 years
People
6,430 worldwide
Run by
Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01
Phase 2Taking people
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Where
Esplugues de Llobregat
Age
12 months to 21 years
People
93 worldwide
Run by
Giselle Sholler
See details and how to joinNCT05489887 · EU 2025-524140-35-00
Phase 1Enrolling by invitation
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Where
Seville
People
250 worldwide
Run by
USWM CT, LLC
See details and how to joinNCT03391778
Phase 2Taking people
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Where
Barcelona, Esplugues de Llobregat, Madrid, San Cristóbal de La Laguna, Seville, Valencia
Age
1 year to 39 years
People
105 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05999994
Phase 1Taking people
A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART)
Where
Madrid
Age
Up to 64 years
People
10
Run by
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
See details and how to join2023-509723-41-01 · EU 2023-509723-41-01
Phase 1Taking people
Early phase clinical trial to evaluate the safety of the combination of immunotherapy with dendritic cells pulsed and tumor lysate, together with CAR-T cells targeting IL13Ra2, in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
Where
Esplugues de Llobregat
Age
Up to 64 years
People
15
Run by
Fundacio Sant Joan De Deu
See details and how to join2024-514052-32-00 · EU 2024-514052-32-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 1Taking people
Trial to evaluate CAR-T NKG2D CAR cell infusions in patients with advanced sarcoma
Where
Madrid
Age
Up to 64 years
People
18
Run by
Hospital Universitario La Paz
See details and how to join2024-513514-35-00 · EU 2024-513514-35-00
No phaseTaking people
Hospital and Home Rehabilitation Based on Social Care Robotics and Artificial Intelligence for Pediatric Patients
Where
Madrid
Age
7 years to 16 years
People
30
Run by
Inrobics Social Robotics, S.L.
See details and how to joinNCT07448103